Suchergebnisse - "Takayama, Tadatoshi"

PubPharm (17)

1

Adjuvant chemotherapy can prolong recurrence-free survival but did not influence the type of recurrence or subsequent treatment in patients with colorectal liver metastases

enthalten in: Surgery | 2021

von Kokudo, T. | Saiura, A. | Takayama, T. | +15

2

Analysis of Patient Outcome after Non-curative Resection for Hepatocellular Carcinoma Using Nationwide Survey Data in Japan

enthalten in: World journal of surgery | 2021

von Aoki, T. | Kubota, K. | Kubo, S. | +10

3

Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort

enthalten in: Annals of surgery | 2019

von Kaibori, M. | Yoshii, K. | Hasegawa, K. | +13

4

Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer

enthalten in: American journal of clinical oncology | 2017

von Kochi, M. | Fujii, M. | Kanamori, N. | +7

5

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice : a subgroup analysis of GIDEON

enthalten in: Journal of gastroenterology | 2016

von Kudo, M. | Ikeda, M. | Takayama, T. | +8

6

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups : The GIDEON study

enthalten in: Journal of hepatology | 2016

von Marrero, J. | Kudo, M. | Venook, A. | +15

7

CR of All Target Lesions in a Patient with Metastatic Esophageal Cancer and Generalized Weakness Treated with Systemic Chemotherapy after Nutritional Support

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2016

von Fujisaki, S. | Takashina, M. | Tomita, R. | +2

8

Regional differences in sorafenib-treated patients with hepatocellular carcinoma : GIDEON observational study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Kudo, M. | Lencioni, R. | Marrero, J. | +15

9

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice : Final Analysis of GIDEON

enthalten in: Radiology | 2016

von Geschwind, J. | Kudo, M. | Marrero, J. | +15

10

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM) : a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Oncology | 2015

von Bruix, J. | Takayama, T. | Mazzaferro, V. | +18

CommentIn: Lancet Oncol. 2015 Oct;16(13):1279-81. - PMID 26433814